BIOCIUS Life Sciences, Inc. is the developer of the RapidFire technology, an ultra high throughput Mass Spectrometry system which enables researchers to gain a more complete understanding of the biochemical properties of compounds.
Catalyst was a lead investor.
News / Links
More Info
Acquired By
Agilent Technologies (NYSE: A) in 2011
